A phase 1-2 clinical trial of gene therapy for recurrent glioblastoma multiforme by tumor transduction with the herpes simplex thymidine kinase gene followed by ganciclovir. GLI328 European-Canadian Study Group
(Q45862712)
scientific article published in September 1999
scientific article published in September 1999
Language:
other details
description | scientific article published in September 1999 |
External Links
(P356) |
10.1089/10430349950016979
|
(P698) |
10515452
|